Latest news
Moleculin reports interim results from MIRACLE trial in r/r AML patients - YahooYahoo · Mon, 03 Aug 2026 09:51:21 GMTMoleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - globenewswire.comglobenewswire.com · Fri, 31 Jul 2026 12:10:00 GMT